What is Koning?
Koning Health is a pioneering medical technology firm specializing in advanced breast imaging. Their flagship product, the Koning Vera Breast CT (KBCT), revolutionizes early breast cancer detection by providing high-resolution 3D imaging without the need for patient compression. This innovative approach aims to enhance diagnostic accuracy and improve patient comfort and outcomes. With a robust portfolio of over 120 patents, Koning is dedicated to making its cutting-edge imaging solutions accessible globally, positioning itself as a leader in women's health diagnostics.
How much funding has Koning raised?
Koning has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Koning
PPP
Public-Private Partnership
What's next for Koning?
The substantial late-stage funding, characterized as a major strategic investment, signals Koning's readiness for significant market expansion and technological scaling. This capital will likely be directed towards broadening the adoption of the KBCT system, further research and development for next-generation imaging technologies, and strengthening its global commercial presence. The company's strong patent foundation and commitment to innovation suggest a trajectory focused on solidifying its leadership in the competitive breast imaging market and potentially exploring new diagnostic applications.
See full Koning company page
